Globus Medical Q3 Revenue Misses Estimates as Non-GAAP EPS Beats

Globus Medical's third-quarter non-GAAP earnings per share beat estimates, while revenue missed forecasts, leaving the results split across the company's two headline measures at $1.23 per share and $763.7 million. The non-GAAP per-share figure exceeded the estimate by 3 cents. Revenue was $28.76 million below estimates and down 0.7% from the same period a year earlier. Separately, sales from Globus Medical's base business, excluding Nevro, totaled $690 million. That figure was up 3% on a reported basis. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Source: TokenPost